Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact

Peleg‐Raibstein, Daria; Sydekum, Esther; Russig, Holger; Feldon, Joram

doi:10.1007/s00213-005-0286-y

Cited by 9 publications

(1 citation statement)

References 69 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The same pattern of effects was observed in other studies that showed no influence of drug withdrawal on the processing of sensory information (Abduljawad et al, 1997;Cabral et al, 2006;Fendt and Mucha, 2001;Peleg-Raibstein et al, 2006). However, there was an unexpected enhancement of the PPI during withdrawal in both sucrose and diazepam groups.…”

Section: Discussionsupporting

confidence: 86%

Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats

Ross

Castilho

Brandão

et al. 2008

Progress in Neuro-Psychopharmacology and Biological Psychiatry

View full text Add to dashboard Cite

It has been demonstrated that, on abrupt withdrawal, patients with chronic exposure can experience a number of symptoms indicative of a dependent state. In clinical patients, the earliest to arise and most persistent signal of withdrawal from chronic benzodiazepine (Bzp) treatment is anxiety. In laboratory animals, anxiety-like effects following abrupt interruption of chronic Bzp treatment can also be reproduced. In fact, signs that oscillate from irritability to extreme fear behaviours and seizures have been described already. As anxiety remains one of the most important symptoms of Bzp withdrawal, in this study we evaluated the anxiety levels of rats withdrawn from diazepam. Also studied were the effects on the motor performance and preattentive sensory gating process of rats under diazepam chronic treatment and upon 48-h withdrawal on three animal models of anxiety, the elevated plus-maze (EPM), ultrasonic vocalizations (USV) and startle + prepulse inhibition tests. Data obtained showed an anxiolytic-and anxiogenic-like profile of the chronic intake of and withdrawal from diazepam regimen in the EPM test, 22-KHz USV and startle reflex.Diazepam chronic effects or its withdrawal were ineffective in promoting any alteration in the prepulse inhibition (PPI). However, an increase of PPI was achieved in both sucrose and diazepam pretreated rats on 48-h withdrawal, suggesting a procedural rather than a specific effect of withdrawal on sensory gating processes. It is also possible that the prepulse can function as a conditioned stimulus to informing the delivery of an aversive event, as the auditory startling-eliciting stimulus. All these findings are indicative of a sensitization of the neural substrates of aversion in diazepam withdrawn animals without concomitant changes on the processing of sensory information.

show abstract

Section: Discussionsupporting

confidence: 86%

Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats

Ross

Castilho

Brandão

et al. 2008

Progress in Neuro-Psychopharmacology and Biological Psychiatry

View full text Add to dashboard Cite

show abstract

Withdrawal

Barr

Boyda

Procyshyn

2010

Animal Models of Drug Addiction

View full text Add to dashboard Cite

Behavioral Animal Models of Antipsychotic Drug Actions

Peleg‐Raibstein

Feldon

Meyer

2012

Handbook of Experimental Pharmacology

View full text Add to dashboard Cite

Basic research in animals represents a fruitful approach to study the neurobiological basis of brain and behavioral disturbances relevant to neuropsychiatric disease and to establish and evaluate novel pharmacological therapies for their treatment. In the context of schizophrenia, there are models employing specific experimental manipulations developed according to specific pathophysiological or etiological hypotheses. The use of selective lesions in adult animals and the acute administration of psychotomimetic agents are indispensable tools in the elucidation of the contribution of specific brain regions or neurotransmitters to the genesis of a specific symptom or collection of symptoms and enjoy some degrees of predictive validity. However, they may be inaccurate, if not inadequate, in capturing the etiological mechanisms or ontology of the disease needed for a complete understanding of the disease and may be limited in the discovery of novel compounds for the treatment of negative and cognitive symptoms of schizophrenia. Under the prevailing consensus of schizophrenia as a disease of neurodevelopmental origin, we have seen the establishment of neurodevelopmental animal models which aim to identify the etiological processes whereby the brain, following specific triggering events, develops into a "schizophrenia-like brain" over time. Many neurodevelopmental models such as the neonatal ventral hippocampus (vHPC) lesion, methylazoxymethanol (MAM), and prenatal immune activation models can mimic a broad spectrum of behavioral, cognitive, and pharmacological abnormalities directly implicated in schizophrenic disease. These models allow pharmacological screens against multiple and coexisting schizophrenia-related dysfunctions while incorporating the disease-relevant concept of abnormal brain development. The multiplicity of existing models is testimonial to the multifactorial nature of schizophrenia, and there are ample opportunities for their integration. Indeed, one ultimate goal must be to incorporate the successes of distinct models into one unitary account of the complex disorder of schizophrenia and to use such unitary approaches in the further development and evaluation of novel antipsychotic treatment strategies.

show abstract

Withdrawal from continuous amphetamine administration abolishes latent inhibition but leaves prepulse inhibition intact

Cited by 9 publications

References 69 publications

Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats

Analysis of the chronic intake of and withdrawal from diazepam on emotional reactivity and sensory information processing in rats

Withdrawal

Behavioral Animal Models of Antipsychotic Drug Actions

Contact Info

Product

Resources

About